Is it Too Late to Buy Marvell Stock? | MRVL Stock Analysis
Summary
Parkev provides a comprehensive reassessment of Marvell Technology (MRVL), a semiconductor company that has seen its stock price surge by approximately 282% over the past year. He acknowledges that the company is ideally positioned to benefit from the ongoing artificial intelligence rally and the growth of large language models. However, despite the strong business fundamentals and market share gains, Parkev's updated financial models suggest that the stock's price appreciation has outpaced its intrinsic growth.
The analysis includes several key revisions to Parkev's valuation spreadsheet. He increased free cash flow (FCF) estimates by roughly $1 billion per year starting in fiscal year 2028, projecting that Marvell's FCF could reach $34 billion by 2035. Additionally, he adjusted the stock's beta upward to 2.28, indicating higher volatility and risk compared to the S&P 500. This higher beta reflects the cyclical nature of the semiconductor industry, which tends to boom or bust alongside broader macroeconomic conditions.
Mentioned Stocks
Reasoning: Parkev concludes that the stock is overvalued at the current market price of approximately $262. His internal valuation, even after revising free cash flow estimates upward by $1 billion per year starting in 2028, yields a fair value of only $173. He explicitly states that he would wait for a 10% to 20% drop in price before considering adding the stock to his portfolio, as the current price has risen too much compared to fundamental improvements.